Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
Clinical trial NCT01696617 · COMPLETED
Trial details
- NCT number
- NCT01696617
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-10
- Primary completion
- 2016-12-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.